Dr. Ronald B Bukowy

M.D. SC | Neurology


  2700 Keslinger Rd, Suite B, Geneva
     Illinois, 60134-4645
  630-262-1500    630-262-1518 Maps & Directions
Dr. Ronald B Bukowy is a Geneva, Illinois based neurologist who is specialized in Neurology. His current practice location is 2700 Keslinger Rd, Suite B, Geneva. Patients can reach him at 630-262-1500 or can fax him at 630-262-1518. Dr. Ronald B Bukowy is M.D. SC in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1922016765.
Dr. Ronald B Bukowy specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Ronald B Bukowy speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Ronald B Bukowy
Specialization: Neurology
Gender:Male
Credentials: M.D. SC
Practice Address:2700 Keslinger Rd, Suite B, Geneva,
Illinois, 60134-4645
Phone:630-262-1500
Fax:630-262-1518
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1922016765
NPI Enumeration Date: 04 Aug, 2006
NPI Last Update On: 02 Jan, 2013

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Ronald B Bukowy
2700 Keslinger Rd, Suite B
Geneva, Illinois
Zip: 60134-4645
Phone Number: 630-262-1500
Fax Number: 630-262-1518
Patients can reach Dr. Ronald B Bukowy at 2700 Keslinger Rd, Suite B, Geneva, Illinois or can call to book an appointment on 630-262-1500.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.